Picture of Solasia Pharma KK logo

4597 — Solasia Pharma KK News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Table: Solasia Pharma -2025 parent results

Feb 13 (Reuters)- 
          Solasia Pharma K. K. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Dec 31, 2025    Dec 31, 2024   Dec 31, 2026     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            429 mln         316 mln                               
                 (+35.4 pct)     (-48.7 pct)                             
  Operating     loss 871 mln    loss 840 mln                             
  Recurring     loss 897 mln    loss 869 mln                             
  Net           loss 897 mln    loss 868 mln                             
  EPS           loss 3.78 yen   loss 4.37 yen                            
  EPS Diluted   loss 3.78 yen   loss 4.37 yen                            
  Ann Div            NIL             NIL            NIL                  
  -Q2 Div            NIL             NIL            NIL                  
  -Q4 Div            NIL             NIL            NIL                  
  
  NOTE - Solasia Pharma K. K.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4597.T

Recent news on Solasia Pharma KK

See all news